Top Markets
Coin of the day
LexaGene Holdings Inc. LexaGene Holdings Inc.

LexaGene Holdings Inc.

0V43
Rank in Stocks #30875
LexaGene Holdings Inc. is a biotechnology firm specializing in the invention,... LexaGene Holdings Inc. is a biotechnology firm specializing in the invention, refinement, and commercialization of systems for detecting pathogens. The company's flagship product, MiQLab, is an automated pathogen identification system engineered to revolutionize diagnostics in diverse sectors, including animal and human healthcare, food and water quality assurance, and other life science applications. This advanced platform functions directly at the location of sample collection, providing remarkable simplicity, heightened sensitivity, and extensive pathogen screening capabilities. Founded in 2007, LexaGene is headquartered in Beverly, Massachusetts.
Share Price
$0.1174299
Last synced: 2023-02-22
Market Cap
$15.21M
Change (1 day)
-0.92%
Change (1 year)
0.00%
Country
US
Trade LexaGene Holdings Inc. (0V43)

Category

P/S ratio for LexaGene Holdings Inc. (0V43)
P/S ratio as of 2026 TTM: 0
According to LexaGene Holdings Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for LexaGene Holdings Inc. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
10.17 -
US
10.13 -
NL
2.95 -
AU
- -
CH
4.74 -
BE